한글목차

피부 생검 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 18억 6,000만 달러에서 2026년에는 20억 2,000만 달러로, CAGR 8.3%로 확대될 전망입니다. 지난 몇 년간의 성장 요인으로는 피부암 발생률의 증가, 피부과 클리닉의 증가, 외래 진단의 보급, 생검 장비의 가용성, 조기 진단에 대한 인식의 증가 등을 들 수 있습니다.

피부 생검 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 27억 4,000만 달러에 달하고, CAGR은 8.0%가 될 전망입니다. 예측 기간의 성장 요인으로는 악성 흑색종 사례 증가, AI를 활용한 진단법 도입, 원격 피부과 진료 확대, 고령화 인구 증가, 미용 피부과 성장 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 최소침습 생검 기술, 피부과 진단 확대, 펀치 생검 및 면도 생검 선호, 외래 진단 절차, AI 지원 병리 통합 등을 들 수 있습니다.

의료비 지출 증가도 피부 생검 시장 성장에 기여할 것으로 예상됩니다. 의료비 지출은 의료 서비스, 치료, 인프라, 조사, 공중 보건 프로그램에 할당된 총 자금을 의미하며, 건강 상태를 개선하기 위한 목적으로 사용됩니다. 이 증가의 주요 요인은 장기 치료와 고가의 치료를 필요로 하는 만성질환의 증가입니다. 의료에 대한 투자 확대는 첨단 진단 도구에 대한 접근성 확대와 피부과 서비스 확대로 이어집니다. 이를 통해 피부 질환의 조기 및 정확한 진단을 지원하여 환자 치료 및 의료 시스템 전반의 성능을 향상시킬 수 있습니다. 예를 들어, 2024년 5월 영국 정부 기관인 국가통계청은 2023년 의료비 지출이 전년 대비 5.6% 증가했다고 보고했습니다(전년 증가율 0.9%). 따라서 의료비 지출의 증가는 피부 생검 시장의 발전에 중요한 역할을 하고 있습니다.

피부 생검 시장에서 사업을 전개하는 주요 기업들은 진단 정확도와 조직 샘플의 품질 향상을 목표로 반자동 생검 장비와 같은 첨단 솔루션 개발에 주력하고 있습니다. 반자동 생검 기기는 제어되고 정확한 조직 채취가 가능하도록 설계되어 정확한 진단 가능성을 높이고 병리학자가 상세한 분석을 수행할 수 있도록 합니다. 예를 들어, 2023년 5월 미국의 중재 및 종양학 기기 솔루션 전문 기업인 Argon Medical Devices는 SuperCore Advantage 반자동 생검 기기를 발표했습니다. 이 기기는 조직 채취량을 증가시키고 다양한 임상적 요구 사항을 충족시키기 위해 다양한 길이와 게이지 크기로 제공됩니다. 의료 전문가들의 의견을 반영하여 개발된 일회용 차세대 일회용 기구로, 임상적 요구에 부응하는 제품입니다. 슈퍼 코어 어드밴티지(Super Core Advantage)는 의사가 더 큰 조직 샘플을 안정적으로 채취할 수 있도록 하며, 정확하고 일관된 생검 성능을 보장합니다. 또한, 바이오핀치, 울트라 풀코어 생검기구, 슈퍼코어 반자동, 트루코어 오토매틱, 프로마그 울트라 생검기구 등 아르곤의 기존 제품 라인업을 보완할 수 있는 제품입니다. 이번 출시를 통해 아르곤은 연부조직 생검 기기의 주요 공급업체로서의 입지를 더욱 강화하는 한편, 환자들의 치료 성과 향상에 기여하고자 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

A skin biopsy is a medical procedure in which a small sample of skin tissue is removed for diagnostic or research purposes. It is used to diagnose skin conditions, including infections, inflammatory disorders, and skin cancers, by examining the cellular structure of the tissue. This procedure helps clinicians determine the nature, severity, and appropriate treatment for various skin abnormalities.

The primary types of skin biopsy are excisional biopsy, incisional biopsy, punch biopsy, shave biopsy, and needle biopsy. Excisional biopsy involves surgically removing an entire lump, lesion, or suspicious tissue area along with a margin of normal surrounding tissue for microscopic examination. Procedure types include surgical biopsy, image-guided biopsy, dermatoscopic biopsy, and endoscopic biopsy. Applications include dermatology, oncology, pathology, clinical research, and cosmetic procedures. Key end-users include hospitals, ambulatory surgical centers (ASCs), diagnostic laboratories, research institutions, and dermatology clinics.

Tariffs have increased costs for imported biopsy instruments, blades, and pathology consumables. North America and Europe are most affected due to reliance on precision surgical tools. Hospitals and dermatology clinics face procurement cost pressure, while tariffs are promoting domestic manufacturing of biopsy devices.

The skin biopsy market research report is one of a series of new reports from The Business Research Company that provides skin biopsy market statistics, including skin biopsy industry global market size, regional shares, competitors with a skin biopsy market share, detailed skin biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the skin biopsy industry. This skin biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The skin biopsy market size has grown strongly in recent years. It will grow from $1.86 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increase in skin cancer incidence, growth in dermatology clinics, adoption of outpatient diagnostics, availability of biopsy instruments, awareness of early diagnosis.

The skin biopsy market size is expected to see strong growth in the next few years. It will grow to $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to rising melanoma cases, AI-enabled diagnostics adoption, expansion of tele-dermatology, aging population, growth in cosmetic dermatology. Major trends in the forecast period include minimally invasive biopsy techniques, dermatology diagnostic expansion, punch and shave biopsy preference, outpatient diagnostic procedures, ai-assisted pathology integration.

The rise in healthcare expenditure is also expected to contribute to the growth of the skin biopsy market. Healthcare expenditure refers to the total financial resources allocated to medical services, treatments, infrastructure, research, and public health programs aimed at improving health outcomes. A key reason for this increase is the growing number of chronic health conditions, which often require long-term care and costly interventions. Greater investment in healthcare leads to broader access to advanced diagnostic tools and expanded dermatological services. This supports early and accurate diagnosis of skin conditions and enhances patient care and overall health system performance. For instance, in May 2024, the Office for National Statistics, a government organization in the United Kingdom, reported a five point six percent increase in healthcare spending during 2023, compared to a zero point nine percent increase in the prior year. Consequently, the growth in healthcare expenditure is playing a significant role in the development of the skin biopsy market.

Major companies operating in the skin biopsy market are concentrating on the development of advanced solutions, such as semi-automatic biopsy instruments, to improve diagnostic precision and the quality of tissue samples. Semi-automatic biopsy instruments are engineered to enable controlled and accurate tissue collection, increasing the chances of a correct diagnosis and allowing pathologists to conduct thorough analyses. For example, in May 2023, Argon Medical Devices, a US-based company specializing in interventional and oncology device solutions, introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument. This device provides enhanced tissue volume and is offered in a comprehensive range of lengths and gauge sizes to accommodate different clinical requirements. It is a disposable, next-generation instrument developed with input from healthcare professionals to address clinical demands. The SuperCore Advantage enables physicians to obtain larger tissue samples with confidence, ensures precise and consistent biopsy performance, and complements Argon's existing product lineup, which includes the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This launch further reinforces Argon's position as a prominent supplier of soft tissue biopsy devices while contributing to improved patient outcomes.

In April 2023, Aurora Diagnostics LLC, a US-based provider of anatomic pathology and diagnostic laboratory services, completed the acquisition of DermPath New England, LLC, for an undisclosed sum. Through this acquisition, Aurora Diagnostics broadened its nationwide dermatopathology network, reinforcing diagnostic expertise and expanding service reach for physicians who depend on timely and precise skin biopsy analysis. DermPath New England is a US-based dermatopathology laboratory specializing in comprehensive diagnostic assessment of skin biopsy samples for referring healthcare providers.

Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the skin biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The skin biopsy market includes revenues earned by entities through skin tissue collection procedures, histopathological examination, molecular and immunohistochemistry testing, diagnostic pathology reporting services, and follow-up consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Skin Biopsy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses skin biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for skin biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The skin biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type Of Biopsy: Excisional Biopsy; Incisional Biopsy; Punch Biopsy; Shave Biopsy
• 2) By Application: Dermatology; Oncology; Clinical Research
• 3) By End-User: Hospitals; Ambulatory Surgical Centers (ASCs); Dermatology Clinics
• Subsegments:
• 1) By Excisional Biopsy: Full-Thickness Excision; Elliptical Excision
• 2) By Incisional Biopsy: Wedge Biopsy; Longitudinal Biopsy; Keyhole Biopsy
• 3) By Punch Biopsy: 2 Millimeter (mm) Punch; 3-4 Millimeter (mm) Punch; Greater Than Or Equal To (>=) 5 Millimeter (mm) Punch
• 4) By Shave Biopsy: Tangential Shave; Saucerization Shave; Curved Blade Shave
• Companies Mentioned: AccuTec Inc.; Delasco; KAI Medical; Medline Industries; Becton Dickinson and Company; Merit Medical Systems; Cook Medical; Hologic; Olympus Corporation; KARL STORZ; Richard Wolf; ConMed; Integra LifeSciences; Paramount Surgimed; Sklar Instruments; Hu-Friedy; Aesculap; World Precision Instruments; Miltex; Integra Miltex
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Skin Biopsy Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Skin Biopsy Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Skin Biopsy Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Skin Biopsy Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Autonomous Systems, Robotics & Smart Mobility
  • 4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
• 4.2. Major Trends
  • 4.2.1 Minimally Invasive Biopsy Techniques
  • 4.2.2 Dermatology Diagnostic Expansion
  • 4.2.3 Punch And Shave Biopsy Preference
  • 4.2.4 Outpatient Diagnostic Procedures
  • 4.2.5 Ai-Assisted Pathology Integration

5. Skin Biopsy Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Dermatology Clinics
• 5.3 Diagnostic Laboratories
• 5.4 Ambulatory Surgical Centers
• 5.5 Research Institutes

6. Skin Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Skin Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Skin Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Skin Biopsy Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Skin Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Skin Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Skin Biopsy Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Skin Biopsy Market Segmentation

• 9.1. Global Skin Biopsy Market, Segmentation By Type Of Biopsy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy
• 9.2. Global Skin Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dermatology, Oncology, Clinical Research
• 9.3. Global Skin Biopsy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics
• 9.4. Global Skin Biopsy Market, Sub-Segmentation Of Excisional Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Full-Thickness Excision, Elliptical Excision
• 9.5. Global Skin Biopsy Market, Sub-Segmentation Of Incisional Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy
• 9.6. Global Skin Biopsy Market, Sub-Segmentation Of Punch Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (>=) 5 Millimeter (mm) Punch
• 9.7. Global Skin Biopsy Market, Sub-Segmentation Of Shave Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tangential Shave, Saucerization Shave, Curved Blade Shave

10. Skin Biopsy Market Regional And Country Analysis

• 10.1. Global Skin Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Skin Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Skin Biopsy Market

• 11.1. Asia-Pacific Skin Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Skin Biopsy Market

• 12.1. China Skin Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Skin Biopsy Market

• 13.1. India Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Skin Biopsy Market

• 14.1. Japan Skin Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Skin Biopsy Market

• 15.1. Australia Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Skin Biopsy Market

• 16.1. Indonesia Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Skin Biopsy Market

• 17.1. South Korea Skin Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Skin Biopsy Market

• 18.1. Taiwan Skin Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Skin Biopsy Market

• 19.1. South East Asia Skin Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Skin Biopsy Market

• 20.1. Western Europe Skin Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Skin Biopsy Market

• 21.1. UK Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Skin Biopsy Market

• 22.1. Germany Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Skin Biopsy Market

• 23.1. France Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Skin Biopsy Market

• 24.1. Italy Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Skin Biopsy Market

• 25.1. Spain Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Skin Biopsy Market

• 26.1. Eastern Europe Skin Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Skin Biopsy Market

• 27.1. Russia Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Skin Biopsy Market

• 28.1. North America Skin Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Skin Biopsy Market

• 29.1. USA Skin Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Skin Biopsy Market

• 30.1. Canada Skin Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Skin Biopsy Market

• 31.1. South America Skin Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Skin Biopsy Market

• 32.1. Brazil Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Skin Biopsy Market

• 33.1. Middle East Skin Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Skin Biopsy Market

• 34.1. Africa Skin Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Skin Biopsy Market, Segmentation By Type Of Biopsy, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Skin Biopsy Market Regulatory and Investment Landscape

36. Skin Biopsy Market Competitive Landscape And Company Profiles

• 36.1. Skin Biopsy Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Skin Biopsy Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Skin Biopsy Market Company Profiles
  • 36.3.1. AccuTec Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Delasco Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. KAI Medical Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Medline Industries Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Skin Biopsy Market Other Major And Innovative Companies

• Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

38. Global Skin Biopsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Skin Biopsy Market

40. Skin Biopsy Market High Potential Countries, Segments and Strategies

• 40.1 Skin Biopsy Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Skin Biopsy Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Skin Biopsy Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer